MX2017009752A - Adn huesped como biomarcador de la enfermedad de crohn. - Google Patents

Adn huesped como biomarcador de la enfermedad de crohn.

Info

Publication number
MX2017009752A
MX2017009752A MX2017009752A MX2017009752A MX2017009752A MX 2017009752 A MX2017009752 A MX 2017009752A MX 2017009752 A MX2017009752 A MX 2017009752A MX 2017009752 A MX2017009752 A MX 2017009752A MX 2017009752 A MX2017009752 A MX 2017009752A
Authority
MX
Mexico
Prior art keywords
subject
diagnosing
crohn
disease
relative abundance
Prior art date
Application number
MX2017009752A
Other languages
English (en)
Other versions
MX376501B (es
Inventor
Cervino Alessandra
Original Assignee
Enterome
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enterome filed Critical Enterome
Publication of MX2017009752A publication Critical patent/MX2017009752A/es
Publication of MX376501B publication Critical patent/MX376501B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se refiere a un método in vitro para diagnosticar la enfermedad de Crohn en un sujeto que comprende: a) obtener una muestra biológica de dicho sujeto, b) analizar la abundancia relativa del ADN huésped en dicha muestra y, c) diagnosticar que dicho sujeto sufre de la enfermedad de Crohn si dicha abundancia relativa es mayor que un valor de referencia. La presente invención se refiere también a un método in vitro para diagnosticar el estado (estable o inestable) de la enfermedad de Crohn en un sujeto, que comprende las etapas de: a) obtener una muestra biológica de dicho sujeto, b) analizar la abundancia relativa del ADN huésped en dicha muestra y c) diagnosticar que dicho sujeto tiene una enfermedad de Crohn en un estado inestable si dicha abundancia relativa es mayor que otro valor de referencia.
MX2017009752A 2015-01-30 2016-01-29 Adn huésped como biomarcador de la enfermedad de crohn. MX376501B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15305142 2015-01-30
PCT/EP2016/051989 WO2016120475A1 (en) 2015-01-30 2016-01-29 Host dna as a biomarker of crohn's disease

Publications (2)

Publication Number Publication Date
MX2017009752A true MX2017009752A (es) 2017-12-07
MX376501B MX376501B (es) 2025-03-07

Family

ID=52577797

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017009752A MX376501B (es) 2015-01-30 2016-01-29 Adn huésped como biomarcador de la enfermedad de crohn.

Country Status (12)

Country Link
US (2) US9873914B2 (es)
EP (1) EP3250710B1 (es)
JP (1) JP6585175B2 (es)
CN (1) CN107208159A (es)
AU (1) AU2016211113A1 (es)
BR (1) BR112017014978A2 (es)
CA (1) CA2973307A1 (es)
ES (1) ES2693973T3 (es)
IL (1) IL253327B (es)
MX (1) MX376501B (es)
PL (1) PL3250710T3 (es)
WO (1) WO2016120475A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3250710T3 (pl) * 2015-01-30 2019-02-28 Enterome DNA gospodarza jako biomarker choroby Crohna
EP3606325B1 (en) 2017-04-03 2024-09-04 Gusto Global, LLC Rational design of microbial-based biotherapeutics
CN112005115A (zh) 2018-02-12 2020-11-27 10X基因组学有限公司 表征来自单个细胞或细胞群体的多种分析物的方法
CN108220286A (zh) * 2018-03-28 2018-06-29 上海锐翌生物科技有限公司 粪便宿主dna甲基化检测方法
CN114882944B (zh) * 2022-06-22 2024-09-20 深圳微伴医学检验实验室 基于Metagenome测序的肠道微生物样品宿主性别鉴定方法、装置及应用
EP4495262A1 (en) 2023-07-21 2025-01-22 Luxia Scientific Host dna as a biomarker of vaginal health

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586177B1 (en) * 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
US20040259101A1 (en) * 2003-06-20 2004-12-23 Shuber Anthony P. Methods for disease screening
CN101238224A (zh) * 2005-06-06 2008-08-06 惠氏公司 炎性肠病的外周血单核细胞的表达谱
RU2313576C1 (ru) * 2006-05-29 2007-12-27 Ростовский-на-Дону научно-исследовательский противочумный институт Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека РЕКОМБИНАНТНАЯ ПЛАЗМИДА, ЭКСПРЕССИРУЮЩАЯ КЛОНИРОВАННЫЙ ГЕН Ace VIBRIO CHOLERAE И ШТАММ ESCHERICHIA COLI-ПРОДУЦЕНТ ACCESSORY CHOLERAE ENTEROTOXIN VIBRIO CHOLERAE
EP2097540A4 (en) * 2006-11-17 2010-09-01 Genizon Biosciences Inc GENETIC CARD OF HUMAN GENES ASSOCIATED WITH CROHN'S DISEASE
CA2701341C (en) * 2007-11-20 2012-03-20 Johann Karl Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
EP2377883A1 (en) * 2010-04-15 2011-10-19 Universite d'Auvergne Clermont I Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease
GB201107466D0 (en) * 2011-05-05 2011-06-15 Loktionov Alexandre Device and method for non-invasive collection of colorectal mucocellular layer and disease detection
EP2721173A1 (en) * 2011-06-14 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for determining the expression level of a gene of interest including correction of rt-qpcr data for genomic dna-derived signals
CN103911440B (zh) * 2014-03-13 2015-04-22 南京医科大学 一种与铂类化疗药物肝脏毒性相关的snp标志物及其应用
PL3250710T3 (pl) * 2015-01-30 2019-02-28 Enterome DNA gospodarza jako biomarker choroby Crohna

Also Published As

Publication number Publication date
CA2973307A1 (en) 2016-08-04
WO2016120475A1 (en) 2016-08-04
AU2016211113A1 (en) 2017-09-07
IL253327B (en) 2020-06-30
US10793911B2 (en) 2020-10-06
IL253327A0 (en) 2017-09-28
ES2693973T3 (es) 2018-12-17
EP3250710B1 (en) 2018-08-22
BR112017014978A2 (pt) 2018-03-20
US20180251844A1 (en) 2018-09-06
US20160258017A1 (en) 2016-09-08
CN107208159A (zh) 2017-09-26
JP2018504909A (ja) 2018-02-22
EP3250710A1 (en) 2017-12-06
JP6585175B2 (ja) 2019-10-02
PL3250710T3 (pl) 2019-02-28
MX376501B (es) 2025-03-07
US9873914B2 (en) 2018-01-23

Similar Documents

Publication Publication Date Title
MX2017009752A (es) Adn huesped como biomarcador de la enfermedad de crohn.
EP4524255A3 (en) Methods and compositions for nucleic acid analysis
EA201892489A1 (ru) Число мишеней для мультиплексной оптимизированной амплификации с несоответствиями (moma)
BR112017017025A2 (pt) métodos e composições para analizar componentes celulares
MX2015012437A (es) Esteroides neuroactivos, composiciones, y usos de los mismos.
EA201792389A1 (ru) Пцр в реальном времени для мультиплексной оптимизированной амплификации с несоответствиями (moma) и для оценки неклеточной днк
EA201692157A1 (ru) Синтез двухцепочечных нуклеиновых кислот
EP4219744A3 (en) Methods of preparing nucleic acids for sequencing
MX364812B (es) Método para extraer características morfológicas de una muestra de material biológico.
AR090973A1 (es) Anticuerpos utiles para el diagnostico del cancer
EA201891291A1 (ru) Мультиспецифические антитела
MX2016016898A (es) Metodos y composiciones para analisis de muestras.
MX2016016902A (es) Metodos para analizar acidos nucleicos de celulas individuales o poblaciones de celulas.
EP4282977C0 (en) ANALYSIS OF MULTIPLE SPATIALLY DIFFERENTIATED NUCLEIC ACIDS FROM ORGANIC SPECIMENS
EA201691607A1 (ru) Микроорганоиды и способы их получения и применения
EP4556576A3 (en) Methods to diagnose and treat acute respiratory infections
EA201890747A1 (ru) Способы лечения воспалительных заболеваний
MY187050A (en) Cancer cell-specific antibody, anticancer agent, and cancer testing method
BR112014025520A2 (pt) método para estimar características de uma formação
BR112017016897A2 (pt) cepas fúngicas e métodos de uso
EA201790769A1 (ru) Определение уровней гликозаминогликанов методом масс-спектрометрии
EA201790504A1 (ru) Монослой мононуклеарных клеток периферической крови или клеток костного мозга и его применение
EA201990730A1 (ru) Рнк-биомаркеры для наследственного ангионевротического отека
EA201691682A1 (ru) Способы анализирования редких циркулирующих в крови клеток
EA201792538A1 (ru) Способ биологического получения метакриловой кислоты

Legal Events

Date Code Title Description
FG Grant or registration